X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs DR. DATSONS LABS - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA DR. DATSONS LABS SANOFI INDIA/
DR. DATSONS LABS
 
P/E (TTM) x 32.8 -10.9 - View Chart
P/BV x 6.3 0.2 3,851.8% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 SANOFI INDIA   DR. DATSONS LABS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
DR. DATSONS LABS
Mar-14
SANOFI INDIA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs4,560126 3,630.6%   
Low Rs4,40031 14,239.5%   
Sales per share (Unadj.) Rs1,028.5133.0 773.3%  
Earnings per share (Unadj.) Rs129.00.2 85,061.3%  
Cash flow per share (Unadj.) Rs186.06.6 2,814.5%  
Dividends per share (Unadj.) Rs68.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs753.6128.8 585.2%  
Shares outstanding (eoy) m23.0331.66 72.7%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.40.6 740.3%   
Avg P/E ratio x34.7516.1 6.7%  
P/CF ratio (eoy) x24.111.8 203.4%  
Price / Book Value ratio x5.90.6 978.4%  
Dividend payout %52.70-   
Avg Mkt Cap Rs m103,1742,477 4,164.6%   
No. of employees `0003.6NA-   
Total wages/salary Rs m3,59256 6,414.3%   
Avg. sales/employee Rs Th6,537.7NM-  
Avg. wages/employee Rs Th991.4NM-  
Avg. net profit/employee Rs Th819.8NM-  
INCOME DATA
Net Sales Rs m23,6864,211 562.5%  
Other income Rs m70879 899.6%   
Total revenues Rs m24,3944,289 568.7%   
Gross profit Rs m5,281569 928.8%  
Depreciation Rs m1,313204 642.4%   
Interest Rs m15430 3.5%   
Profit before tax Rs m4,66113 36,700.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6916 27,721.3%   
Profit after tax Rs m2,9705 61,875.0%  
Gross profit margin %22.313.5 165.1%  
Effective tax rate %36.348.0 75.5%   
Net profit margin %12.50.1 10,999.1%  
BALANCE SHEET DATA
Current assets Rs m15,6736,852 228.7%   
Current liabilities Rs m6,6786,711 99.5%   
Net working cap to sales %38.03.3 1,134.0%  
Current ratio x2.31.0 229.9%  
Inventory Days Days76161 47.2%  
Debtors Days Days22318 7.0%  
Net fixed assets Rs m8,0983,673 220.5%   
Share capital Rs m230317 72.7%   
"Free" reserves Rs m17,0883,761 454.3%   
Net worth Rs m17,3564,078 425.7%   
Long term debt Rs m01,671 0.0%   
Total assets Rs m25,40012,633 201.1%  
Interest coverage x311.71.0 30,279.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.3 279.8%   
Return on assets %11.83.4 341.3%  
Return on equity %17.10.1 14,536.5%  
Return on capital %26.97.7 351.1%  
Exports to sales %24.522.9 107.0%   
Imports to sales %28.014.3 195.7%   
Exports (fob) Rs m5,801964 601.8%   
Imports (cif) Rs m6,627602 1,101.0%   
Fx inflow Rs m7,145964 741.2%   
Fx outflow Rs m6,846607 1,127.7%   
Net fx Rs m299357 83.8%   
CASH FLOW
From Operations Rs m3,2261,345 239.9%  
From Investments Rs m-1,555-2,256 68.9%  
From Financial Activity Rs m-1,818-1,200 151.5%  
Net Cashflow Rs m-147-2,111 7.0%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 0.0 -  
FIIs % 14.6 1.4 1,081.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 94.1 11.2%  
Shareholders   15,184 20,807 73.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   MERCK LTD  CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  STERLING BIOTECH  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jan 23, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - PIRAMAL ENTERPRISES COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS